Summary & Overview
CPT 82554: Creatine Kinase Isoform Analysis
CPT code 82554 designates laboratory measurement of creatine kinase (CK) isoforms, a targeted isoenzyme analysis used to distinguish specific CK subtypes in a patient specimen. Nationally, CK isoform testing contributes to diagnostic pathways for muscle injury, myocardial damage, and certain neuromuscular disorders where isoenzyme differentiation informs clinical interpretation. The code is most commonly billed for quantitative laboratory services performed in clinical or hospital laboratories.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for CK isoform testing, the typical site and service type, and what to expect in payer coverage and billing practice. The publication summarizes benchmark considerations and coding guidance where available, highlights common modifiers and billing nuances, and outlines implications for laboratory workflow and documentation. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 82554 reports measurement of creatine kinase (CK) isoforms, which are related variants or subdivisions of the creatine phosphokinase (CPK) isoenzymes. The service involves laboratory analysis to quantify the different CK isoforms present in a patient specimen, supporting clinical evaluation of muscle injury, myocardial injury, and related conditions.
Service Type: Clinical Laboratory — Quantitative Isoenzyme Analysis
Typical Site of Service: Clinical laboratory or hospital laboratory
Data not available in the input for payers, taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or outpatient clinic with acute chest pain, recent blunt chest trauma, or suspected skeletal muscle injury. The clinician orders cardiac and muscle biomarkers to evaluate for myocardial injury and to differentiate cardiac from skeletal muscle sources of elevated creatine kinase (CK). A blood specimen is collected and sent to the clinical laboratory. The laboratory performs isoenzyme fractionation to measure creatine kinase isoforms (CK-MB, CK-MM, CK-BB) to help distinguish cardiac muscle injury (elevated CK-MB) from skeletal muscle damage (predominant CK-MM). Results are reported in the electronic medical record and communicated to the ordering provider for interpretation alongside troponin, ECG, and imaging. Typical sites of service include hospital inpatient laboratories, hospital outpatient clinics, emergency departments, and independent clinical reference laboratories performing serum enzyme isoform analysis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when the physician interprets and reports the laboratory result separate from the technical processing by the lab |
52 | Reduced services | Use when the lab performs a limited version of the test with decreased work or intensity |
53 | Discontinued procedure | Use if specimen collection or testing was started but discontinued for documented clinical reasons |
59 | Data not available in the input. | Data not available in the input. |
90 | Reference (outside) laboratory | Use when testing is performed by an outside, independent reference laboratory |
TC | Technical component | Use when billing for the laboratory processing and equipment component only |
QX | Ordering physician-certified nurse-midwife/supplier | Use when applicable under molecular/diagnostic supervision rules for non-physician practitioners (if applicable) |
QY | Medically supervised lab personnel | Use when the service is performed under the physician supervision model for outpatient labs |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services furnished in part-time | Use when those practitioners perform parts of the service under applicable supervision rules |
90 | Data not available in the input. | Data not available in the input. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Clinical Laboratory | Pathologists and clinical laboratory specialists who oversee testing |
| 207L00000X | Medical Laboratory Technologist/Technician | Technologists who perform the actual isoenzyme assays |
| 208D00000X | General Practice | Ordering providers in emergency or outpatient settings who request the test |
| 207P00000X | Pathology | Pathologists who provide interpretive consultation on complex results |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I21.9 | Acute myocardial infarction, unspecified | CK isoforms (notably CK-MB) assist in diagnosing myocardial infarction in conjunction with troponin and ECG |
S20.221A | Contusion of left chest wall, initial encounter | Chest wall trauma can elevate total CK and isoforms; isoenzyme testing helps differentiate cardiac vs skeletal injury |
M62.81 | Rhabdomyolysis | Marked elevation of CK-MM isoform is expected; isoform testing helps confirm skeletal muscle source |
M60.9 | Myositis, unspecified | Muscle inflammation produces elevated CK, isoform pattern supports skeletal muscle origin |
R07.9 | Chest pain, unspecified | Ordered in the evaluation of undifferentiated chest pain to help rule in/out myocardial injury |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
82550 | Creatine kinase (CK) | Often ordered together as a total CK provides baseline enzyme activity before isoenzyme fractionation |
82555 | Creatine kinase, MB isoenzyme (CK-MB) | Alternative or complementary code used when reporting CK-MB specifically by immunoassay |
82551 | Aldolase, total | May be ordered alongside CK isoforms when evaluating skeletal muscle disease |
84484 | Troponin I or T, quantitative | Commonly ordered concurrently to assess myocardial injury and improve diagnostic specificity for acute coronary syndromes |
80053 | Comprehensive metabolic panel | Frequently ordered in the same encounter to evaluate overall metabolic status and contributors to muscle injury |